Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Bivalirudin in Infants with Thrombosis
NCT00043277Phase 2Completed
- Sponsor
- The Medicines Company
- Start
- Aug 2002
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bivalirudin in thrombosis, sponsored by The Medicines Company. Primary endpoint: Observation of improvement for thrombosis. Started Aug 2002; status: completed.
02
Drugs
bivalirudin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT00043277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043277.